Ray Dalio Boston Scientific Corp Transaction History

Bridgewater Associates, LP

$20.7 Billion
Q1 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Boston Scientific Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 63,954 shares of BSX stock, worth $6.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

63,954

Previous 162,913 60.74%

Holding current value

$6.7 Million

Previous $14.6 Million 55.67%

% of portfolio

0.03%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$89.38 - $106.18 $8.84 Million - $10.5 Million	-98,959 Reduced 60.74%	63,954 $6.45 Million
Q4 2024 Feb 13, 2025	SELL	$83.62 - $91.5 $16.2 Million - $17.7 Million	-193,851 Reduced 54.34%	162,913 $14.6 Million
Q3 2024 Nov 13, 2024	SELL	$72.96 - $84.0 $59.5 Million - $68.5 Million	-815,182 Reduced 69.56%	356,764 $29.9 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $11.6 Million - $13.4 Million	-172,553 Reduced 12.83%	1,171,946 $90.3 Million
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $23.8 Million - $28.3 Million	-413,013 Reduced 23.5%	1,344,499 $92.1 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $1.09 Million - $1.3 Million	22,416 Added 1.29%	1,757,512 $102 Million
Q3 2023 Nov 13, 2023	SELL	$50.19 - $54.68 $178,074 - $194,004	-3,548 Reduced 0.2%	1,735,096 $91.6 Million
Q2 2023 Aug 11, 2023	SELL	$49.72 - $54.64 $10.1 Million - $11.1 Million	-203,590 Reduced 10.48%	1,738,644 $94 Million
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $135,675 - $150,540	-3,009 Reduced 0.15%	1,942,234 $97.2 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $25.3 Million - $30.3 Million	-640,797 Reduced 24.78%	1,945,243 $90 Million
Q3 2022 Nov 10, 2022	BUY	$36.71 - $109.66 $9.97 Million - $29.8 Million	271,504 Added 11.73%	2,586,040 $100 Million
Q2 2022 Aug 11, 2022	SELL	$35.24 - $47.1 $11.7 Million - $15.6 Million	-331,476 Reduced 12.53%	2,314,536 $86.3 Million
Q1 2022 May 13, 2022	BUY	$40.9 - $45.1 $33.5 Million - $36.9 Million	818,484 Added 44.79%	2,646,012 $117 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $11 Million - $12.9 Million	287,729 Added 18.69%	1,827,528 $77.6 Million
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $1.36 Million - $1.52 Million	-33,071 Reduced 2.1%	1,539,799 $66.8 Million
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $23.1 Million - $26.4 Million	597,739 Added 61.3%	1,572,870 $67.3 Million
Q1 2021 May 14, 2021	BUY	$35.27 - $39.67 $8.92 Million - $10 Million	252,959 Added 35.03%	975,131 $37.7 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $13 Million - $16.5 Million	392,204 Added 118.86%	722,172 $26 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $11.4 Million - $13.9 Million	329,968 New	329,968 $12.6 Million
Q2 2020 Aug 12, 2020	SELL	$30.19 - $39.11 $477,243 - $618,250	-15,808 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$25.83 - $45.71 $408,320 - $722,583	15,808 New	15,808 $516,000
Q4 2019 Feb 13, 2020	SELL	$37.87 - $45.37 $1.01 Million - $1.21 Million	-26,571 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$40.31 - $43.45 $566,960 - $611,124	14,065 Added 112.47%	26,571 $1.08 Million
Q2 2019 Aug 13, 2019	SELL	$34.91 - $42.98 $1.01 Million - $1.24 Million	-28,819 Reduced 69.74%	12,506 $538,000
Q1 2019 May 14, 2019	SELL	$32.91 - $40.75 $1.96 Million - $2.43 Million	-59,525 Reduced 59.02%	41,325 $1.59 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $1.9 Million - $2.15 Million	-75,229 Reduced 42.72%	100,850 $2.76 Million
Q4 2017 Feb 13, 2018	BUY	$24.79 - $29.8 $4.36 Million - $5.25 Million	176,079	176,079 $4.37 Million

Others Institutions Holding BSX

# of Institutions

1,873

Shares Held

1.22B

Call Options Held

9.89M

Put Options Held

7.29M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $150B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account